openPR Logo
Press release

GENESIS Biomed consolidates its growth in the biomedical sector

11-20-2023 08:57 AM CET | Health & Medicine

Press release from: Barcelona Science Park

/ PR Agency: Barcelona Science Park
GENESIS Biomed consolidates its growth in the biomedical sector

The consultancy firm GENESIS Biomed -with its central offices at the Barcelona Science Park and offices in Madrid and Valencia, and a reference in advisory services for R&D&i projects in the biomedical sector- will close this financial year with a record turnover of €2M, 25% more than in 2022, thanks to an exclusively organic growth strategy and an ambitious national expansion plan.

In 2023, the consultancy, founded by Josep Lluís Falcó and Natalia de la Figuera, has collaborated in more than 60 early-stage R&D&i projects, from accompaniment in the constitution process of spin-offs and startups, the creation of the business plan, valuation of the product through a development plan or creation of the financing plan. The identification in the latter of the financial needs will enable the strategy for raising private funds to be defined, in which the consultancy will also accompany these companies.

So far this year, GENESIS Biomed has taken part in the closure of the €1M round of Renalyse with the Botín Foundation, and is providing support in raising private funds for another three companies in the sector. And through its vehicle GENESIS Tech Transfer Boost, it has carried out another two transactions, that of the spin-off Retina Read Risk and the startup Spinally Medical, and has a third underway which will be published shortly.

GENESIS Biomed also habitually collaborated with research centres, companies investors and other stakeholders in the biomedical sector, working on strategic plans, analysis of investments, valuations of companies and accompaniment in incubation and acceleration processes, among others.

Since its foundation, in May 2017, the company has done 308 consultancy projects for 260 clients, and has contributed to closing a total of 20 financing rounds, raising more than €68.5M for its clients, with the aim of contributing to the knowledge generated in universities and hospitals materialising in companies that develop innovative solutions to improve people's health and quality of life.

Inauguration of its new headquarters in the Valencia BioHub

Within the framework of the ambitious national expansion plan, GENESIS Biomed has opened offices in the BioHub VLC, the first privately managed Spanish business centre dedicated to health and life sciences.

In the words of Josep Lluís Falcó, founder and CEO of the consultancy: The opening of these headquarters is decision of GENESIS Biomed to invest in the Valencian Community which is positioning itself as one of the main clusters in Biomedicine, bringing together a significant number of Health Research Institutes and Research Foundations. For our part, we have a very relevant presence in this sector and we are working with projects in the field of technology transfer and advisory services for biomedical projects connected with the university (UV, UPV, UHM), health (IIS La Fe, Incliva, Isabial, Fisabio), entrepreneurial (Corify, Arthex, Sonda, Doppli) and corporate settings (Inndromeda, CIBER-BBN).

To consolidate its presence within this eco-system, GENESIS Biomed has also incorporated Bioval as a partner. This cluster represents and connects business interests and BIO entities in the community.

According to Natalia de la Figuera, founder, managing partner and COO: "Our participation in this cluster will enable us to unite forces to share and expand knowledge to thus generate added value that directly impacts people's health. We are very excited about this new opportunity that is open to us and we hope to be able to contribute our experience in the development of the Biomedicine sector in this Bioregion".

The inauguration of these new headquarters was held yesterday within the framework of the Annual GENESIS Biomed Conference in Valencia. The event, which was opened by Jesús Agüero, director general of Bioval, was attended by more than 75 professionals from public entities and companies from the biomedicine community eco-system.

In the words of Ángela Pérez, president of Bioval: "We are happy with the incorporation of GENESIS Biomed in the large family that forms Bioval. The concentration of specialised professionals and biotechnological sector projects in such a unique place as the Biohub VLC helps us to retain talent and attract investment, essential levers to make this sector of the future grow".

Promote the growth of its Madrid office

Last September, GENESIS Biomed incorporated the lawyer Antonio Rodríguez Hita as the new Director of the company's offices opened in Madrid in 2019.

Rodríguez Hita has more than 14 years of international experience in technology transfer. He has worked for the University of Calabria (Italy), the Hospital de La Princesa Research Institute, the Gregorio Marañón Health Research Institute and spent a year at the Technology Transfer Office of the National Institutes of Health (NIH). During his career in the Innovation Support Unit (UAI) at the Gregorio Marañón Health Research Institute (IiSGM), he led work teams, developed strategic alliances, designed health entrepreneurship programmes, negotiated technology transfer agreements and gave legal advice on industrial property.

His career and knowledge will enable the expansion of the GENESIS Biomed portfolio of services with two new categories: consultancy services related to the design of the intellectual and industrial property protection strategy, and legal advice services in the incorporation of companies and technology licence agreements.

This new recruit will enable GENESIS Biomed to consolidate its expansion in the Community of Madrid, a community with a large number of companies, billing and investment in R&D and with great potential.

Barcelona Science Park
C/Baldiri Reixac, 4-12 i 15
08028 Barcelona

The Barcelona Science Park is one of Europe's model ecosystems in research, technology transfer and innovation, covering a built-up surface area of more than 100,000 m² with some 3,000 professionals working mainly in the health sector: pharmacology, biotechnology, medical technologies, food and cosmetics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GENESIS Biomed consolidates its growth in the biomedical sector here

News-ID: 3292402 • Views:

More Releases from Barcelona Science Park

IDIBAPS and ISGlobal, research centres linked to the Clínic, join the Barcelona Science Park
IDIBAPS and ISGlobal, research centres linked to the Clínic, join the Barcelona …
The Barcelona Science Park of the University of Barcelona (UB) will host two new research centres with ties to Barcelona's Hospital Clínic: the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Barcelona Institute for Global Health (ISGlobal). The move is the first step in setting up the future Campus Clínic of Barcelona on Avinguda Diagonal, which will have more than 290,000 square metres given over to healthcare, teaching
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary therapy against disabling and lethal haemorrhage
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary th …
A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institut Català d'Investigació Química (ICIQ), has received 2.5 million euros from AEI, the State Investigation Agency, under the call for grants for Public-Private Collaboration Projects, to accelerate the development of an innovative treatment aimed at controlling disabling and lethal haemorrhage. The aim of the project, led by Hemostatics -
MeteoSim wins World Bank competition to implement a numerical weather forecasting model in Malawi
MeteoSim wins World Bank competition to implement a numerical weather forecastin …
MeteoSim, the global leader in the provision of meteorological and environmental services, has won a prestigious competition sponsored by the World Bank as part of its Development Project P161392: the "Malawi Resilience and Disaster Risk Management Project", to implement a numerical weather forecasting model for Department of Climate Change and Meteorological Services of Malawi to train the country's meteorological team, thus reinforcing their position as a global benchmark in the
Barcelona Science Park refinances the €36.7 M debt with the Ministry of Science and Innovation
Barcelona Science Park refinances the €36.7 M debt with the Ministry of Scienc …
Barcelona Science Park (PCB) has refinanced the €36.7 M debt due with the Ministry of Science and Innovation over 25 years. This new schedule allows the PCB to have a stable financial position, both in the short and the long term, as well as consolidating its self-sustaining financial feasibility. The Government of Catalonia and the University of Barcelona support the refinancing, the first offering itself as a guarantor to the

All 5 Releases


More Releases for Biomed

Biomed Washer Market Size, Players, Revenue Analysis 2023-2030
Biomed Washer Market Overview 2023: The Biomed Washer Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the Biomed Washer market. This report explores all the key factors affecting the growth of the Biomed Washer
Breast Prosthesis Market Key Players Insights - Arion Laboratories, GC Aesthetic …
Breast Prosthesis Market Insights A breast prosthesis is a form of artificial breast that can replace the shape and size of part or all shape of the breast which is removed. The breast Prosthesis device can fit into the bra cup with or without a bra even. In general, soft silicone gel are encased in a thin film which are used to prepare the breast prosthesis. The shaped devices are molded
Breast Implants Market – Future Demanding Applications 2025 | Sientra, Hans Bi …
Global Breast Implants Market: Overview Women in particular possess a heightened conscience about their appearance and looks. A growing number of women are employing various methods to enhance their physical appearance. Breast implantation is one of the trends that has been increasingly popular among women. Breast implantation surgery has seen tremendous change on account of the technological advancements in the cosmetic surgery field. Most women have a high preference for enhancing
01-25-2019 | Health & Medicine
Fact.MR
Global Breast Prosthesis Market Trends, Opportunities & Growth Forecast during 2 …
Increase in the prevelance rate of cancer across the globe is the major growth driver of Global Breast Prosthesis Market .Efficient treatment and body balance provided to the patient when the breast is removed or no longer balanced act as a Global Breast Prosthesis Market driver.  Breast Prosthesis are also used in cases where women do not have identical breast which is expected to increase the growth of Global Breast
Breast Implants Market - Upcoming Industry Need 2025 | Sientra, Hans Biomed
Global Breast Implants Market: Snapshot The global market for breast implants has been growing at a robust rate on account of several medical and physiological factors that have surfaced across the world. The development of new and advanced techniques for breast implants have proved to be a boon for the global market and is expected to further enhance the growth prospects of the market players. Breast implants are a form of
LIMS Software Market Is Thriving Worldwide | Sunquest, Accutest, BioMeD
A new business intelligence report released by HTF MI with title “Global LIMS Software Market Size, Status and Forecast 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: